المؤلفون: Tsegaye T, Gebretekle GB, Ahmed MH, Bayissa T, Habte BM

المصدر: Journal of Asthma and Allergy, Vol Volume 15, Pp 1055-1063 (2022)

مصطلحات موضوعية: asthma, treatment outcome, uncontrolled asthma, severity, exacerbations and trigger factors., Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.dovepress.com/asthma-treatment-outcome-and-factors-associated-with-uncontrolled-asth-peer-reviewed-fulltext-article-JAA; https://doaj.org/toc/1178-6965

URL الوصول: https://doaj.org/article/9288990614ef4ec992d4d9e71447a05c

المؤلفون: Erku, D, Mersha, AG, Ali, EE, Gebretekle, GB, Wubishet, BL, Kassie, GM, Mulugeta, A, Mekonnen, Alemayehu, Eshetie, TC, Scuffham, P

مصطلحات الفهرس: cost-effectiveness, economic evaluation, Ethiopia, Science & Technology, Life Sciences & Biomedicine, Health Care Sciences & Services, Health Policy & Services, COST-EFFECTIVENESS ANALYSIS, CARE DECISIONS, PUBLIC-FINANCE, SOUTH-AFRICA, STATE, INTERVENTIONS, VACCINATION, STRATEGIES, PREPARE, ACCESS, Journal Article

URL: http://hdl.handle.net/10536/DRO/DU:30164342
http://doi.org/10.1093/heapol/czac005
http://elements.deakin.edu.au/viewobject.html?id=298640&cid=1
issn: 0268-1080
issn: 1460-2237
http://doi.org/10.1093/heapol/czac005
http://elements.deakin.edu.au/viewobject.html?id=298640&cid=1
Health Policy and Planning

المؤلفون: Gebretekle, GB, Fenta, TG

المصدر: Ethiopian Journal of Health Development; Vol 27, No 2 (2013); 124-133

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=78975075580c::6d49b1a5d5ccfbeb16b77df823d1eab6
https://www.ajol.info/index.php/ejhd/article/view/115340

المؤلفون: Gebretekle, GB, Tekie, M, Shonora, F, Teshager, M, Hogan, M

المصدر: In Value in Health October-November 2017 20(9):A930-A931

المؤلفون: Tuite AR; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que. ashleigh.tuite@phac-aspc.gc.ca., Simmons AE; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Rudd M; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Cernat A; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Gebretekle GB; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Yeung MW; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Killikelly A; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Siu W; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Buchan SA; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Brousseau N; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que., Tunis M; Centre for Immunization Programs (Tuite, Simmons, Rudd, Cernat, Gebretekle, Yeung, Killikelly, Siu, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Dalla Lana School of Public Health (Tuite, Simmons, Rudd, Buchan), University of Toronto, Toronto, Ont.; Health Policy PhD Program (Cernat), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; School of Epidemiology and Public Health (Siu), Faculty of Medicine, University of Ottawa, Ottawa, Ont.; Health Protection (Buchan), Public Health Ontario, Toronto, Ont.; Direction des risques biologiques (Brousseau), Institut national de santé publique du Québec, Québec, Que.

المصدر: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2024 Sep 09; Vol. 196 (29), pp. E989-E1005. Date of Electronic Publication: 2024 Sep 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Canadian Medical Association Country of Publication: Canada NLM ID: 9711805 Publication Model: Electronic Cited Medium: Internet ISSN: 1488-2329 (Electronic) Linking ISSN: 08203946 NLM ISO Abbreviation: CMAJ Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis* , Respiratory Syncytial Virus Infections*/prevention & control , Respiratory Syncytial Virus Infections*/economics , Respiratory Syncytial Virus Vaccines*/economics , Quality-Adjusted Life Years*, Humans ; Canada ; Aged ; Middle Aged ; Female ; Male ; Age Factors ; Vaccination/economics ; Aged, 80 and over ; Immunization Programs/economics

المؤلفون: Gebretekle GB; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada., Yeung MW; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada., Ximenes R; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada., Cernat A; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada; Health Policy PhD Program, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada., Simmons AE; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Killikelly A; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada., Siu W; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada., Rafferty E; Institute of Health Economics, Edmonton, AB, Canada; Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Brousseau N; Biological Risks Unit, Institut national de santé publique du Québec, Québec, Canada; Department of Social and Preventive Medicine, Université Laval, Québec, Canada., Tunis M; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada., Tuite AR; Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: ashleigh.tuite@phac-aspc.gc.ca.

المصدر: Vaccine [Vaccine] 2024 Aug 30; Vol. 42 (21), pp. 126164. Date of Electronic Publication: 2024 Jul 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Respiratory Syncytial Virus Infections*/prevention & control , Respiratory Syncytial Virus Infections*/economics , Cost-Benefit Analysis* , Respiratory Syncytial Virus Vaccines*/economics , Respiratory Syncytial Virus Vaccines*/therapeutic use , Respiratory Syncytial Virus Vaccines*/administration & dosage , Antibodies, Monoclonal, Humanized*/economics , Antibodies, Monoclonal, Humanized*/therapeutic use , Palivizumab*/therapeutic use , Palivizumab*/economics , Quality-Adjusted Life Years*, Humans ; Infant ; Canada ; Female ; Antiviral Agents/economics ; Antiviral Agents/therapeutic use ; Respiratory Syncytial Virus, Human/immunology ; Respiratory Syncytial Virus, Human/drug effects ; Male ; Infant, Newborn

المؤلفون: Achalu DL; Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia., Kiltu AB; Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia., Teferi M; Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia., Mohammed FG; Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia., Workneh BD; Department of Social and Administrative Pharmacy, Wollo University, Dessie, Ethiopia., Beyene KA; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy in St. Louis, St. Louis, MO, USA., Gebretekle GB; Canada's Drug and Health Technology Agency, Toronto, ON, Canada., Ali EE; Department of Pharmaceutics and Social Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia. eskinder.eshetu@aau.edu.et.

المصدر: BMC infectious diseases [BMC Infect Dis] 2024 Aug 17; Vol. 24 (1), pp. 837. Date of Electronic Publication: 2024 Aug 17.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Tuberculosis, Multidrug-Resistant*/drug therapy , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/therapeutic use , Injections*, Humans ; Retrospective Studies ; Female ; Ethiopia ; Male ; Adult ; Treatment Outcome ; Young Adult ; Middle Aged

المؤلفون: Ogunbameru A; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. adeteju.ogunbameru@mail.utoronto.ca.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, ON, Canada. adeteju.ogunbameru@mail.utoronto.ca., Gebretekle GB; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, ON, Canada., Perryman A; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, ON, Canada.; School of Global Health, York University - Keele Campus, Toronto, ON, Canada., Hassan M; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, ON, Canada., Farrell A; Library & Information Services, University Health Network, Toronto, ON, Canada., Liu K; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Mishra S; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Department of Medicine, Division of Infectious Disease, University of Toronto, Toronto, ON, Canada.; Centre of Urban Health Solutions, St, Michael's Hospital, Toronto, ON, Canada.; ICES, Toronto, ON, Canada., Sander B; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, ON, Canada.; Public Health Ontario, Toronto, ON, Canada.; ICES, Toronto, ON, Canada.

المصدر: BMC public health [BMC Public Health] 2024 Aug 05; Vol. 24 (1), pp. 2106. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Pandemics*, Humans ; COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19/economics ; Developed Countries ; Relief Work/economics ; Epidemics/prevention & control ; Health Equity

المؤلفون: Fentie AM; Addis Ababa University, College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Ethiopia. Electronic address: atalay.mulu@aau.edu.et., Huluka SA; Addis Ababa University, College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Ethiopia., Gebremariam GT; Addis Ababa University, College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Ethiopia., Gebretekle GB; University Health Network, Toronto Health Economics and Technology Assessment (THETA) Collaborative, Canada., Abebe E; Purdue University, College of Pharmacy, West Lafayette, IN, USA; Indiana University, School of Medicine, Indianapolis, IN, USA., Fenta TG; Addis Ababa University, College of Health Sciences, School of Pharmacy, Department of Social Pharmacy and Pharmaceutics, Ethiopia.

المصدر: Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2024 May; Vol. 20 (5), pp. 487-497. Date of Electronic Publication: 2024 Feb 14.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101231974 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1934-8150 (Electronic) Linking ISSN: 15517411 NLM ISO Abbreviation: Res Social Adm Pharm

مواضيع طبية MeSH: Drug-Related Side Effects and Adverse Reactions*/prevention & control , Neoplasms*/drug therapy , Pharmacists*, Humans ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Medication Adherence ; Medication Errors/prevention & control ; Professional Role ; Randomized Controlled Trials as Topic

المؤلفون: Negash Z; College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia., Tadiwos A; College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia., Urgessa EM; College of Health Sciences, School of Medicine, Department of Dermato-Venereology, Addis Ababa University, Addis Ababa, Ethiopia., Gebretekle GB; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.; University Health Network, Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, Canada., Abebe E; College of Pharmacy, Purdue University, West Lafayette, IN, USA.; School of Medicine, Indiana University, Indianapolis, IN, USA., Fentie AM; College of Health Sciences, School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia. atalay.mulu@aau.edu.et.

المصدر: Health and quality of life outcomes [Health Qual Life Outcomes] 2023 May 04; Vol. 21 (1), pp. 38. Date of Electronic Publication: 2023 May 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525 (Electronic) Linking ISSN: 14777525 NLM ISO Abbreviation: Health Qual Life Outcomes Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus*/drug therapy , Diabetes Mellitus*/epidemiology , Quality of Life*, Female ; Humans ; Male ; Cross-Sectional Studies ; Ethiopia ; Hospitals ; Insulin/therapeutic use ; Surveys and Questionnaires ; Middle Aged